Interpretable Causal Representation Learning for Biological Data in the Pathway Space
Authors:
Jesus de la Fuente,
Robert Lehmann,
Carlos Ruiz-Arenas,
Jan Voges,
Irene Marin-Goñi,
Xabier Martinez-de-Morentin,
David Gomez-Cabrero,
Idoia Ochoa,
Jesper Tegner,
Vincenzo Lagani,
Mikel Hernaez
Abstract:
Predicting the impact of genomic and drug perturbations in cellular function is crucial for understanding gene functions and drug effects, ultimately leading to improved therapies. To this end, Causal Representation Learning (CRL) constitutes one of the most promising approaches, as it aims to identify the latent factors that causally govern biological systems, thus facilitating the prediction of…
▽ More
Predicting the impact of genomic and drug perturbations in cellular function is crucial for understanding gene functions and drug effects, ultimately leading to improved therapies. To this end, Causal Representation Learning (CRL) constitutes one of the most promising approaches, as it aims to identify the latent factors that causally govern biological systems, thus facilitating the prediction of the effect of unseen perturbations. Yet, current CRL methods fail in reconciling their principled latent representations with known biological processes, leading to models that are not interpretable. To address this major issue, we present SENA-discrepancy-VAE, a model based on the recently proposed CRL method discrepancy-VAE, that produces representations where each latent factor can be interpreted as the (linear) combination of the activity of a (learned) set of biological processes. To this extent, we present an encoder, SENA-δ, that efficiently compute and map biological processes' activity levels to the latent causal factors. We show that SENA-discrepancy-VAE achieves predictive performances on unseen combinations of interventions that are comparable with its original, non-interpretable counterpart, while inferring causal latent factors that are biologically meaningful.
△ Less
Submitted 14 June, 2025;
originally announced June 2025.
Towards a more inductive world for drug repurposing approaches
Authors:
Jesus de la Fuente,
Guillermo Serrano,
Uxía Veleiro,
Mikel Casals,
Laura Vera,
Marija Pizurica,
Antonio Pineda-Lucena,
Idoia Ochoa,
Silve Vicent,
Olivier Gevaert,
Mikel Hernaez
Abstract:
Drug-target interaction (DTI) prediction is a challenging, albeit essential task in drug repurposing. Learning on graph models have drawn special attention as they can significantly reduce drug repurposing costs and time commitment. However, many current approaches require high-demanding additional information besides DTIs that complicates their evaluation process and usability. Additionally, stru…
▽ More
Drug-target interaction (DTI) prediction is a challenging, albeit essential task in drug repurposing. Learning on graph models have drawn special attention as they can significantly reduce drug repurposing costs and time commitment. However, many current approaches require high-demanding additional information besides DTIs that complicates their evaluation process and usability. Additionally, structural differences in the learning architecture of current models hinder their fair benchmarking. In this work, we first perform an in-depth evaluation of current DTI datasets and prediction models through a robust benchmarking process, and show that DTI prediction methods based on transductive models lack generalization and lead to inflated performance when evaluated as previously done in the literature, hence not being suited for drug repurposing approaches. We then propose a novel biologically-driven strategy for negative edge subsampling and show through in vitro validation that newly discovered interactions are indeed true. We envision this work as the underpinning for future fair benchmarking and robust model design. All generated resources and tools are publicly available as a python package.
△ Less
Submitted 24 November, 2023; v1 submitted 21 November, 2023;
originally announced November 2023.
